The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...

According to a 2018 article, at least 25 percent of adults have metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease.

Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...

A blood test looking for five specific proteins can predict metabolic dysfunction-associated steatotic liver disease (MASLD), ...

In this Healio interview, Gideon Hirschfield, PhD, MB BChir, the Lily and Terry Horner Chair in Autoimmune Liver Disease Research at University of Toronto, discusses how primary biliary ...

Nonalcoholic fatty liver disease (NAFLD) has limited dietary treatment options. Here, the authors show that torularhodin, a microbial carotenoid, alleviates NAFLD by enriching Akkermansia ...